Jason A. Clemens, former Chief Financial Officer of AdaptHealth Corp., filed a Form 144 notice on November 12, 2026, proposing to sell 19,855 shares of AdaptHealth common stock with an aggregate market value of $154,712.15.
Key Highlights
- Proposed sale: 19,855 shares of AdaptHealth Corp. common stock, with an aggregate market value of $154,712.15, through Morgan Stanley Smith Barney LLC Executive Financial Services.
- Approximate sale date: November 11, 2026, with the Form 144 filed on November 12, 2026 due to EDGAR being unavailable on November 11 in observance of a federal holiday.
- Shares outstanding: According to the filing, 136,525,348 shares of common stock were outstanding at the time of the notice.
- Acquisition history: The shares proposed for sale were acquired through restricted stock vestings under a registered plan, in transactions dated February 28, 2022; March 2, 2022; February 28, 2023; July 13, 2023; and August 10, 2023, all paid for by services rendered.
- Recent prior sales: Clemens sold 169,779 shares on November 5, 2026, for gross proceeds of $1,260,743.41, and 60,978 shares on November 6, 2026, for gross proceeds of $447,510.44, according to the filing's three-month sales table.
- Exchange listed: NASDAQ:AHCO, as identified in the filing.
Clemens Proposes Additional AdaptHealth Share Sale Following November Transactions
According to the Form 144 notice filed with the U.S. Securities and Exchange Commission, Jason A. Clemens, identified in the filing as former CFO of AdaptHealth Corp. (NASDAQ:AHCO), proposed the sale of 19,855 shares of the company's common stock. The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker for the transaction. The approximate date of sale is listed as November 11, 2026.
The shares proposed for sale were obtained through five separate restricted stock vestings under a registered plan, with the issuer listed as the acquiring party in each case. The vesting dates ranged from February 28, 2022 to August 10, 2023, and the nature of payment in each instance is described as "Services Rendered." The five tranches consisted of 2,167 shares, 1,590 shares, 1,544 shares, 13,834 shares, and 720 shares, respectively, as detailed in the filing.
The filing also discloses that Clemens sold a combined 230,757 shares during the three months preceding this notice: 169,779 shares on November 5, 2026, generating gross proceeds of $1,260,743.41, and 60,978 shares on November 6, 2026, generating gross proceeds of $447,510.44. A remark in the filing states that "Sales that were executed on November 11, 2026 are being reported on this Form 144 filed on November 12, 2026 given the EDGAR system was not accepting filings on November 11, 2026 in observance of the federal holiday."
What Was Disclosed
AdaptHealth Corp.'s former CFO, Jason A. Clemens, filed a Form 144 notice proposing the sale of 19,855 common shares with an aggregate market value of $154,712.15, acquired through restricted stock vestings between 2022 and 2023, with the sale routed through Morgan Stanley Smith Barney LLC.



Please wait processing your request...